D-0081-2022 Class II Terminated
FDA drug recall D-0081-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Oct 5, 2021 and is designated Class II. Reason for recall: Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity The recall status is terminated (terminated Feb 16, 2023). Affected quantity: a) 776 bottles, b) 84 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 10, 2021
- Initiation Date
- Oct 5, 2021
- Termination Date
- Feb 16, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 776 bottles, b) 84 bottles
Product description
Dr. Reddy's Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, a) 90 count (NDC 43598-742-90) and b) 1000 count (NDC 43598-742-10) bottles, Rx only, Manufactured by: Dr. Reddy's Laboratories LA LLC, Shreveport, LA 71106, USA, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 USA, , packaged in bottles.
Reason for recall
Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity
Distribution pattern
Nationwide in the US
Code information
a) L100256, exp 01/2023; b) L100257, exp 01/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0081-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026